RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Alzheimer's Channel

subscribe to Alzheimer's newsletter
Latest Research : Aging : Dementia : Alzheimer's

   EMAIL   |   PRINT
Coronary bypass surgery increases risk of Alzheimer's disease

Aug 25, 2005 - 1:43:00 PM
"Heart bypass surgery represents a traumatic insult to the brain, particularly by reducing oxygen supply to the brain and increasing the stress response"

[RxPG] Boston University School of Medicine (BUSM) researchers have discovered that patients who have either coronary artery bypass graft surgery or coronary angioplasty are at an increased risk of developing Alzheimer's disease.

The research, which appears in the current issue of the Journal of Alzheimer's Disease (http://www.j-alz.com), pinpoints stress and trauma of the surgery as the major cause for the increased risk.

Led by Benjamin Wolozin, MD, PhD, professor of pharmacology at BUSM, researchers compared 5,216 people who underwent coronary artery bypass graft surgery (CABG) and 3,954 people who had a percutaneous transluminal coronary angioplasty (PTCA) in 1996 and 1997. Over the course of five years, 78 of the patients who had bypass surgery and 41 of those who had angioplasty developed Alzheimer's disease.

"The coronary bypass patients had a 70 percent increased risk of developing Alzheimer's disease," said Wolozin, co-author of the study. "This increased incidence of neurocognitive degeneration associated with heart bypass surgery provides further incentive for more studies to better characterize the risks of cardiac surgery on the brain."

According to Wolozin, previous studies show some heart surgery patients experience memory problems immediately following the procedure. However, at a one-year follow-up most patients regain cognitive function.

Researchers believe this early cognitive impairment is an immediate reaction to the stress of surgery.

"Heart bypass surgery represents a traumatic insult to the brain, particularly by reducing oxygen supply to the brain and increasing the stress response," said Wolozin.

"We believe that the compensation that occurs by one year masks an underlying deficit in the central nervous system caused by the heart surgery. As individuals age, this underlying deficit might exacerbate progressive cognitive deficits associated with mild cognitive impairment, a precursory phase before diagnosis of Alzheimer's."

Wolozin and his researchers are currently working with researchers from the Framingham Heart Study to determine if these same observations can be duplicated in their studies.

"If these observations are confirmed, there are measures that can be taken to protect the brain during heart bypass surgery," explained Wolozin. "Antioxidants might offer some protection, as well as memantine, a medication that helps slow the progression of Alzheimer's disease. There may also be other neuroprotective agents still in development that could shield the brain from cognitive degeneration during and following surgery."

Publication: The article is "Assessment of the Emergence of Alzheimer's Disease Following Coronary Artery Bypass Graft Surgery or Percutaneous Transluminal Coronary Angioplasty" by Todd A. Lee, Benjamin Wolozin, Kevin B. Weiss and Martin M. Bednar (Communicated by Craig Atwood). It appears in the Journal of Alzheimer's Disease, Vol. 7, Number 4 published by IOS Press.
On the web: Journal of Alzheimer's Disease 

Advertise in this space for $10 per month. Contact us today.

Related Alzheimer's News

Subscribe to Alzheimer's Newsletter

Enter your email address:

 Additional information about the news article
About the Journal of Alzheimer's Disease
The Journal of Alzheimer's Disease (www.j-alz.com) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease.

About IOS Press
Commencing its publishing activities in 1987, IOS Press (www.iospress.com) is a rapidly expanding scientific, technical, medical and professional publishing house focusing on a broad range of subject areas. Headquartered in Amsterdam, IOS Press publishes approximately 100 new books per annum and 70 international journals, covering topics ranging from computer science and mathematics to medicine and the natural sciences. Electronic access to all journals is now available. IOS Press also maintains offices in the Washington, DC area and Berlin and a co-publishing relationship with Ohmsha, Ltd (Tokyo).
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)